PMA device
QDOT MICRO System
Biosense Webster, Inc. · Catheter, Percutaneous, Cardiac Ablation, For Treatment Of Atrial Fibrillation (OAE, Class III) · First FDA decision Nov 23, 2022, newest Apr 8, 2025Atrial fibrillation
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
4
PMA pathway
Device trials
10
Naming "QDOT MICRO"
MAUDE reports
1,952
Brand "QDOT MICRO", since 2015
PubMed studies
73
Mentioning "QDOT MICRO"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing QDOT MICRO System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 4 of 4 decisions filed under this name.
- QDOT MICRO SystemPMA supplement
P210027-S012 · Decided Apr 8, 2025 · 258 days after receipt · Normal 180 Day Track No User Fee
Device type: Catheter, percutaneous, cardiac ablation, for treatment of atrial fibrillation (OAE) · Cardiology
P210027-S002 · Decided Jul 20, 2023 · 121 days after receipt · Normal 180 Day Track No User Fee
Device type: Catheter, percutaneous, cardiac ablation, for treatment of atrial fibrillation (OAE) · Cardiology
- QDOT MICRO System, nGEN GeneratorPMA supplement
P210027-S001 · Decided Feb 24, 2023 · 87 days after receipt · Normal 180 Day Track
Device type: Catheter, percutaneous, cardiac ablation, for treatment of atrial fibrillation (OAE) · Cardiology
1 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Percutaneous Left Atrial Appendage Closure (LAAC)National determinationOn the books20.34Updated Nov 4, 2026
- Percutaneous Left Atrial Appendage (LAA) Closure TherapyNational analysisReview closedCAG-00445NUpdated Sep 21, 2026
- Cardiac Catheterization Performed In Other Than A Hospital SettingNational analysisReview closedCAG-00166NUpdated Sep 16, 2026
- Cardiac Catheterization Performed in Other than a Hospital Setting - RETIREDNational determinationOn the books20.25Updated Dec 3, 2024
- Cardiac Catheterization and Coronary AngiographyLocal determinationIn effectL33959CGS Administrators, LLCUpdated Oct 30, 2026
- Cardiac Catheterization and Coronary AngiographyLocal determinationIn effectL33557Wellpoint FederalUpdated Jul 14, 2026
- Percutaneous minimally invasive fusion/stabilization of the sacroiliac joint for the treatment of back painLocal determinationIn effectL36000WPS Insurance CorporationUpdated May 21, 2026
Clinical trials
Device studies on ClinicalTrials.gov that name "QDOT MICRO", any status and sponsor, newest update first.
Heart Rhythm Clinical and Research Solutions, LLCAcademic, hospital or other
NCT04088071 · 20,000 participants (planned) · Start Jan 1, 2018 · Primary completion Dec 31, 2028
Device: Catheter ablation · For: Paroxysmal Atrial Fibrillation; Persistent Atrial Fibrillation; Ventricular Arrhythmia
Sites: Birmingham, Alabama; Mobile, Alabama; Chandler, Arizona · 75 sites in all
Heart Rhythm Clinical and Research Solutions, LLCAcademic, hospital or other
NCT06324201 · 250 participants (planned) · Start Feb 27, 2024 · Primary completion Mar 2026
Device: Ablation Procedure · For: Paroxysmal Atrial Fibrillation
Sites: Birmingham, Alabama; Mobile, Alabama; Ventura, California · 21 sites in all
Cedars-Sinai Medical CenterAcademic, hospital or other
NCT06392932 · 30 participants (planned) · Start Oct 4, 2024 · Primary completion Oct 2026
Device: QDOT Micro ablation catheter; ST SF ablation catheter · For: Atrial Fibrillation Paroxysmal
Sites: Los Angeles, California
7 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "QDOT MICRO", and for the whole product code for context.
This brand
1,952 reports: 1,058 malfunction, 827 injury, 66 death
Whole product code OAE
11,261 reports: 5,551 malfunction, 5,370 injury, 334 death
Newest reports for this brand
- QDOT MICROInjury
3013300026-2026-03605 · Received Oct 29, 2026 · Event dated Sep 29, 2026
Device type: Catheter, Percutaneous, Cardiac Ablation, For Treatment Of Atrial Fibrillation (OAE)
Device problem as coded: Patient Device Interaction Problem
Patient problem as coded: Cardiac Perforation
- QDOT MICROInjury
3013300026-2026-03608 · Received Oct 29, 2026 · Event dated Sep 29, 2026
Device type: Catheter, Percutaneous, Cardiac Ablation, For Treatment Of Atrial Flutter (OAD)
Device problem as coded: Patient Device Interaction Problem
Patient problem as coded: Cardiac Tamponade
- QDOT MICROInjury
3013300026-2026-03576 · Received Oct 28, 2026 · Event dated Sep 29, 2026
Device type: Catheter, Percutaneous, Cardiac Ablation, For Treatment Of Atrial Fibrillation (OAE)
Device problem as coded: Patient Device Interaction Problem
Patient problem as coded: Cardiac Perforation
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "QDOT MICRO"[tiab]. The summary above synthesizes these.
- QDOT MICROࡊ versus THERMOCOOL® SMARTTOUCHࡊ and THERMOCOOL SMARTTOUCH® Surround Flow in radiofrequency ablation of paroxysmal atrial fibrillation.
Osorio J, Maccioni S, Sharma R, et al. · J Comp Eff Res · 2023Research Support, Non-U.S. Gov't
- Catheter-related and clinical complications associated with QDOT MICROTM Ablation Catheter.
Kewcharoen J, Shah K, Bhardwaj R, et al. · J Cardiovasc Electrophysiol · 2024
- Biosense Webster's QDOT Microࡊ radiofrequency ablation catheter.
Wielandts JY, Almorad A, Hilfiker G, et al. · Future Cardiol · 2021
- Comparison of three different approaches to very high-power short-duration ablation using the QDOT-MICRO catheter.
Yamaguchi J, Takigawa M, Goya M, et al. · J Cardiovasc Electrophysiol · 2023Research Support, Non-U.S. Gov't
- Ablation of Ventricular Tachycardia Using the QDOT MICRO Ablation Catheter (VT-MICRO Study).
Di Monaco A, Ciliberti D, Martinelli A, et al. · J Arrhythm · 2026
- Cardiac Perforation During High-Power Radiofrequency Ablation of the Left Lateral Ridge Using QDOT MICRO.
Gianni C, Dare M, Sanchez JE, et al. · Circ Arrhythm Electrophysiol · 2024Letter
- Temperature-Controlled Catheter Ablation for Paroxysmal Atrial Fibrillation: the QDOT-MICRO Workflow Sttudy.
Potter T, Grimaldi M, Jensen HK, et al. · J Atr Fibrillation · 2021
- High efficiency single-catheter workflow for radiofrequency atrial fibrillation ablation in the QDOT catheter era.
Valeriano C, Buytaert D, Fabbricatore D, et al. · J Interv Card Electrophysiol · 2024
- Very High-Power Short-Duration, Temperature-Controlled Radiofrequency Ablation in Paroxysmal Atrial Fibrillation: The Prospective Multicenter Q-FFICIENCY Trial.
Osorio J, Hussein AA, Delaughter MC, et al. · JACC Clin Electrophysiol · 2023Multicenter Study, Research Support, Non-U.S. Gov't
- Durable pulmonary vein isolation with optimized high-power and very high-power short-duration temperature-controlled ablation: A step-by-step guide.
De Potter TJR, De Becker B, Duytschaever M · J Cardiovasc Electrophysiol · 2024Research Support, Non-U.S. Gov't
- Characteristics of tissue temperature during ablation with THERMOCOOL SMARTTOUCH SF versus TactiCath versus QDOT MICRO catheters (Qmode and Qmode+): An in vivo porcine study.
Otsuka N, Okumura Y, Kuorkawa S, et al. · J Cardiovasc Electrophysiol · 2024Research Support, Non-U.S. Gov't
- Pulsed field vs very high-power short-duration radiofrequency ablation for atrial fibrillation: Results of a multicenter, real-world experience.
Dello Russo A, Compagnucci P, Anselmino M, et al. · Heart Rhythm · 2024Multicenter Study, Observational Study
Other devices of this type
Also filed under product code OAE.
- Arctic Front Advance and Arctic Front Advance ProMedtronic Cryocath, LP · PMA 2024
- Arctic Front Cardiac Cryoablation Catheter SystemMedtronic Cryocath, LP · PMA 2024
- TactiCath Contact Force Ablation Catheter, Sensor EnabledSt Jude Medical · PMA 2023
- HeartLight Catheter, HeartLight X3 Console V2Cardiofocus, Inc. · PMA 2023
- TactiFlex Sensor Enabled Ablation CatheterAbbott Medical · PMA 2026
- DiamondTemp Ablation SystemMedtronic, Inc. · PMA 2025
- TactiCath Quartz Contact Force Ablation CatheterSt Jude Medical · PMA 2021
- POLARx/POLARx FIT Cryoablation CathetersBoston Scientific Corporation · PMA 2024
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.